/Investor DB

Inkef — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

BioClin TherapeuticsinMay 2018

BiotechSan Leandro, US

Steve Abella(Chief Medical Officer)inGraeme Currie(Chief Operating Officer)inStephen W. Lau(President, Chief Executive Officer, and Treasurer)inKenneth Schwartz(Executive Officer)inEric Yuen(Executive Officer)inMarten Steen(Director)in

Co-investorsEQT Life SciencesHealthCapSectoral Asset ManagementSofinnova VenturesYsios Capital

Castorcastoredc.cominSeed · Jul 2018 · $6MDefunct

Castor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSTel Aviv, IL

Derk Arts(Founder)in

Co-investorsAsahi Kasei Corporate Venture CapitalF-Prime CapitalTechstarsChartered GroupTwo Sigma Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.